Balance Sheet

Accounts Payables Accumulated Expenses Assets Cash & Current Investments Cash & Equivalents Common Equity Construction in Progress Convertible Debt Current Assets Current Deferred Revenue Current Deferred Tax Assets Current Taxes Goodwill Goodwill & Intangibles Intangibles Inventory Land & Improvements Liabilities and Shareholders Equity Liabilities from Discontinued Operations Long-Term Deferred Tax Long-Term Investments Non-Current Assets Non-Current Debt Notes Payables Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Preferred Stock Liabilities Prepaid Assets Property, Plant & Equipment (Net)Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares

Daily Values

Growth Metrics

Others

Ani Pharmaceuticals (ANIP) Buildings: 2012-2013

Ani Pharmaceuticals' Buildings was N/A to $3.7 million in Q3 2013 from the same period last year, while for Sep 2013 it was $3.7 million, marking a year-over-year change of. This contributed to the annual value of $3.7 million for FY2012, which is N/A change from last year.
As of Q3 2013, Ani Pharmaceuticals' Buildings stood at $3.7 million, which was down 0.00% from $3.7 million recorded in Q2 2013.
In the past 5 years, Ani Pharmaceuticals' Buildings ranged from a high of $3.7 million in Q4 2012 and a low of $3.7 million during Q4 2012.
Moreover, its 2-year median value for Buildings was $3.7 million (2013), whereas its average is $3.7 million.